Alvotech reports financial results for full year 2023 and provides a business update

Alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2023 and provided a summary of recent pipeline and corporate highlights. management will conduct a business update conference all and live webcast on march 21, 2024 at 8:00 am et (12:00 pm gmt).
ALVO Ratings Summary
ALVO Quant Ranking